LGALS3BP and atherosclerosis: In conclusion, our work suggests that hepatocyte‐derived EVs in fatty liver tissue can be transferred into the vascular tissue and aggravate atherosclerosis and calcification by transferring Lgals3bp, indicating that this mechanism may represent an important therapeutic target for MAFLD and its extrahepatic complications.